Login to Your Account

Industry's financings craze continues despite global market jitters

By Jennifer Boggs
Managing Editor

Thursday, January 7, 2016

For the second day in a row, the biopharma sector remained undeterred by the red blanketing Wall Street, with 11 firms pricing public offerings expected to total well more than $1.1 billion in funding. (See BioWorld Today, Jan. 7, 2016.)

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription